Mablink Bioscience logo

Mablink Bioscience jobs and careers

Lyon, France

About Mablink Bioscience

Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).

Founded in 2018 by Jean-Guillaume Lafay and Warren Viricel.

Founded
2018
Employees
11 to 50
Total funding
$35M
Headquarters
Lyon

Leadership

The top of Mablink Bioscience's org chart, with how many people report into each leader.

CDPhoto of Carmela Dantas-Barbosa

Carmela Dantas-Barbosa

Director of Translational Research

1 report

VAPhoto of Valérie Attuil

Valérie Attuil

COO

DPPhoto of Delphine BREGEON, PhD, PMP

Delphine BREGEON, PhD, PMP

Director, Head of CMC Operations & Clinical Supply

ELPhoto of Edouard LEROY

Edouard LEROY

Chief Business Development Officer

SPPhoto of Sylvain THIERRY, PhD

Sylvain THIERRY, PhD

Director Pharmacology (Immuno-Oncology and Targeted Therapies)

PBPhoto of Pierrick Bruyat

Pierrick Bruyat

Research Scientist in Medicinal Chemistry